ERGOLOID MESYLATES
CEREBRAL VASODILATORS · DEMENTIA
MUTUAL PHARM CO
Drug class
Ergoloid Mesylates
Ergoloid mesylates refers not to a distinct broad therapeutic class, but rather to a specific fixed-dose drug product belonging to the hydrogenated ergot alkaloid class, consisting of the methanesulfonate salts of dihydroergocornine, dihydroergocristine, and dihydroergocryptine. Read more about Ergoloid Mesylates
1 drugs in this class 1 manufacturers
Drugs in Ergoloid Mesylates
Filter & compare in the drug finder →
Opens the drug finder with Ergoloid Mesylates preselected. Add indication or manufacturer filters there.
Ergoloid mesylates refers not to a distinct broad therapeutic class, but rather to a specific fixed-dose drug product belonging to the hydrogenated ergot alkaloid class, consisting of the methanesulfonate salts of dihydroergocornine, dihydroergocristine, and dihydroergocryptine.
While its exact mechanism of action remains incompletely defined, it functions as a central and peripheral neuromodulator with alpha-adrenergic antagonist, dopaminergic, and metabolic effects without significant vasoconstrictive properties.
Historically, it has been indicated for symptomatic relief in individuals with idiopathic decline in mental capacity, age-related cognitive impairment, and mild dementia syndromes.
-
nih.gov
Ergoloid mesylates refers not to a distinct broad therapeutic class, but rather to a specific fixed-dose drug product belonging to the hydrogenated ergot alkaloid class, consisting of the methanesulfonate salts of dihydroergocornine, dihydroergocristine, and dihydroergocryptine While its exact mechanism of action remains incompletely defined, it functions as a central and peripheral neuromodulator with alpha-adrenergic antagonist, dopaminergic, and metabolic effects without significant vasoconst...
-
umassmed.edu
Ergoloid mesylates refers not to a distinct broad therapeutic class, but rather to a specific fixed-dose drug product belonging to the hydrogenated ergot alkaloid class, consisting of the methanesulfonate salts of dihydroergocornine, dihydroergocristine, and dihydroergocryptine
-
nih.gov
While its exact mechanism of action remains incompletely defined, it functions as a central and peripheral neuromodulator with alpha-adrenergic antagonist, dopaminergic, and metabolic effects without significant vasoconstrictive properties
-
nih.gov
While its exact mechanism of action remains incompletely defined, it functions as a central and peripheral neuromodulator with alpha-adrenergic antagonist, dopaminergic, and metabolic effects without significant vasoconstrictive properties
-
bvsalud.org
Historically, it has been indicated for symptomatic relief in individuals with idiopathic decline in mental capacity, age-related cognitive impairment, and mild dementia syndromes
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.